Utah Medical Products (UTMD) Cash from Financing Activities (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Cash from Financing Activities of -$1.1 million for Q1 2026, up 73.64% year-over-year from -$643273.0 in Q1 2025, and up 43.33% quarter-over-quarter from -$2.0 million in Q4 2025.
Utah Medical Products (UTMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Utah Medical Products' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 73.64% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$9.2 million (up 61.74% YoY), while the FY2025 annual figure was -$12.3 million, up 48.24% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$1.1 million, up from -$2.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $19000.0 in Q1 2022, with the low at -$7.7 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$1.6 million (2025), against an average of -$2.8 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities soared 102.0% in 2022, then sank 5621.05% in 2023.
- Utah Medical Products' Cash from Financing Activities stood at -$920000.0 in 2022, then dropped by 16.41% to -$1.1 million in 2023, then plunged by 623.34% to -$7.7 million in 2024, then soared by 74.56% to -$2.0 million in 2025, then jumped by 43.33% to -$1.1 million in 2026.
- Business Quant data shows UTMD's Cash from Financing Activities at -$1.1 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | -1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.07 Mn |
| Jun 30, 2026 | -1.07 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | -1.97 Mn |
| Dec 31, 2025 | -1.97 Mn |
| Sep 30, 2025 | -1.64 Mn |
| Sep 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | -4.49 Mn |
| Jun 30, 2025 | -4.49 Mn |
| Mar 31, 2025 | -4.24 Mn |
| Mar 31, 2025 | -4.24 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -7.19 Mn |
| Jun 30, 2024 | -7.19 Mn |
| Mar 31, 2024 | -3.98 Mn |
| Mar 31, 2024 | -3.98 Mn |